Apyx Medical Corporation

Informe acción NasdaqGS:APYX

Capitalización de mercado: US$49.2m

Salud financiera de hoja de balance de Apyx Medical

Salud financiera controles de criterios 5/6

Apyx Medical tiene un patrimonio de los accionistas total de $26.9M y una deuda total de $33.2M, lo que sitúa su ratio deuda-patrimonio en 123.3%. Sus activos y pasivos totales son $79.2M y $52.3M respectivamente.

Información clave

123.3%

Ratio deuda-patrimonio

US$33.19m

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$43.65m
PatrimonioUS$26.92m
Total pasivoUS$52.32m
Activos totalesUS$79.24m

Actualizaciones recientes sobre salud financiera

Recent updates

Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive

Apr 18
Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive

Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates

Mar 26
Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates

Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)

Feb 16
Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)

Is Apyx Medical (NASDAQ:APYX) A Risky Investment?

Sep 14
Is Apyx Medical (NASDAQ:APYX) A Risky Investment?

Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?

Jun 07
Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?

Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically

Mar 21
Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically

Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation

Dec 14
Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation

We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate

Aug 30
We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate

Apyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses by $0.26M

Aug 11

Apyx Medical gets FDA nod for Renuvion's use in improving loose skin on neck, chin

Jul 18

Companies Like Apyx Medical (NASDAQ:APYX) Are In A Position To Invest In Growth

May 26
Companies Like Apyx Medical (NASDAQ:APYX) Are In A Position To Invest In Growth

Are Investors Undervaluing Apyx Medical Corporation (NASDAQ:APYX) By 42%?

Mar 15
Are Investors Undervaluing Apyx Medical Corporation (NASDAQ:APYX) By 42%?

We Think Apyx Medical (NASDAQ:APYX) Can Easily Afford To Drive Business Growth

Jan 08
We Think Apyx Medical (NASDAQ:APYX) Can Easily Afford To Drive Business Growth

We Think Apyx Medical (NASDAQ:APYX) Can Easily Afford To Drive Business Growth

Sep 28
We Think Apyx Medical (NASDAQ:APYX) Can Easily Afford To Drive Business Growth

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($70.4M) de APYX superan a sus pasivos a corto plazo ($12.7M).

Pasivo a largo plazo: Los activos a corto plazo de APYX ($70.4M) superan a sus pasivos a largo plazo ($39.6M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: APYX tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de APYX ha crecido de 0.2% a 123.3% en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: APYX tiene suficiente cash runway para más de 3 años basándose en su flujo de caja libre actual.

Pronóstico de cash runway: APYX dispone de suficiente cash runway para 1.6 años si el flujo de caja libre sigue reduciéndose a tasas históricas de 0.5% cada año.


Descubre empresas con salud financiera